RICHMOND MARK 4
4 · OSI PHARMACEUTICALS INC · Filed Feb 3, 2005
Insider Transaction Report
Form 4
RICHMOND MARK
Director
Transactions
- Exercise/Conversion
Common Stock
2005-02-01$16.81/sh+1,500$25,220→ 4,390 total - Sale
Common Stock
2005-02-01$65.10/sh−401$26,105→ 3,788 total - Sale
Common Stock
2005-02-01$65.16/sh−697$45,417→ 2,890 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-02-01−1,500→ 30,500 totalExercise: $16.81From: 2000-04-10Exp: 2010-04-09→ Common Stock (1,500 underlying) - Sale
Common Stock
2005-02-01$65.00/sh−201$13,065→ 4,189 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Exercisable as to 25,000 shares on 04/10/2000 and the remainder on 04/10/2001.
- [F3]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F4]Includes only options with the same termination date.